我要投票 肤阴洁在女性洗液行业中的票数:446
· 外 推 电 报 ·
2025-08-22 08:37:15 星期五

【肤阴洁是哪个国家的品牌?】

肤阴洁是什么牌子?「肤阴洁」是 广西源安堂药业有限公司 旗下著名品牌。该品牌发源于广西贵港市,由创始人莫董在2001年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力肤阴洁品牌出海!将品牌入驻外推网,定制肤阴洁品牌推广信息,可以显著提高肤阴洁产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

具有独立自主知识产权,涵盖OTC/医院/超市等市场板块的诸多产品,集科研/生产/销售/服务于一体的大型中药制药企业


广西源安堂药业有限公司是一个集科研、生产、销售、服务于一体、拥有超亿元固定资产、年生产能力超10亿元规模的广西民族品牌特色药生产企业。

公司行政总部、现代化药品生产基地坐落于广西桂平市中沙镇,公司营销中心及技术研发机构设立在广西首府南宁市。公司现有员工600余人,其中,包括硕士研究生、本科生、大中专生等各类专业技术人才约300余人。

公司成立30年来,结合自身的技术资源和品牌优势,成功研发生产出一系列具有独立自主知识产权的国家新药,投放市场后,产销两旺,丰富了广西民族特色药品的阵营,带来了巨大的社会经济效益。公司主要国药有:肤阴洁®复方黄松洗液、肤阴洁®复方黄松湿巾、源安堂®银胡感冒散、源安堂®肠胃散、源安堂®朱虎化瘀酊等。公司研发生产的几类国药,都是取源于桂东南地道的原生态中药材,精心萃取,科学配伍,各有特色。

经过30多年的锤炼与洗礼,公司各类国药产品,形成了具有“原生态科技创新型”和“市场化品牌实用型”的特点。

肤阴洁®复方黄松洗液和湿巾是公司的支柱产品,自成系列,形成并丰富了涵盖OTC药店销售、医院销售、连锁销售等市场营销体系,在全国近30个省、直辖市、自治区构建起了布局合理的市场营销网络。

源安堂®银胡感冒散、源安堂®肠胃散、源安堂®朱虎化瘀酊是广西乃至全国仅有的民族特色药,显示出独特的疗效。源安堂®银胡感冒散,是以青蒿素为主要成分的创新型国药,广泛应用于小孩、中老年人,其在感冒初期治疗中,成为不打针、不吃药、贴肚脐疗法、治感冒的典范,获得国家发明专利,荣获“世界卫生组织教科文卫部科技发明特别贡献奖”,是广西中成药富有民族特色的药品,在华东、华中、华南市场销售中保持旺盛的势头。源安堂®肠胃散、朱虎化瘀酊等国药产品,在临床实践中各具特色,疗效显著,销售发展潜力很大,具有无限的医药商机和市场价值。

公司发展30多年来,坚持走科技创新、品牌强业的发展道路,努力培育和打造企业核心竞争力,拥有技术发明创造和各项产品商标专利共17项,公司将科技研发成果转化为社会生产力,有利于推动广西社会经济的和谐发展。公司“源安堂”和“肤阴洁”两大品牌的不断推广与发展,为其赋予了丰富的科技内涵和潜在的品牌价值,由于公司国药品牌的影响力、市场销售的增长率和广大消费者的认同感。

广西源安堂药业有限公司将在广西自治区各级党委、政府的正确领导下,在广西食品药品监督管理局和自治区林业厅的精心指导下,结合自身优势,以市场为导向,以研发为动力,以效益为核心,以人为本,苦练内功,加强管理,整合资源,改革创新,励精图治,带动地方经济发展,打造广西民族中药特色品牌,为发展中国中医药和人类健康事业再作贡献。


英文翻译:Guangxi yuanantang Pharmaceutical Co., Ltd. is a large-scale traditional Chinese medicine pharmaceutical enterprise with independent intellectual property rights, covering OTC / hospital / supermarket and other market segments, integrating scientific research / production / sales / service. It is a Guangxi national brand characteristic pharmaceutical manufacturer with fixed assets of more than 100 million yuan and annual production capacity of more than 1 billion yuan 。 The company's administrative headquarters and modern pharmaceutical production base are located in Zhongsha Town, Guiping City, Guangxi Province. The company's marketing center and technical research and development organization are set up in Nanning, the capital city of Guangxi Province. The company has more than 600 employees, including more than 300 professional and technical talents such as master's degree, undergraduate, college and technical secondary school students. In the past 30 years since its establishment, the company has successfully developed and produced a series of national new drugs with independent intellectual property rights in combination with its own technical resources and brand advantages. After being put on the market, the production and marketing of these drugs have flourished, enriching the camp of drugs with national characteristics in Guangxi and bringing huge social and economic benefits. The main Chinese medicines of the company are Fuyinjie (Fuyinjie), Fuyinjie (Fuyinjie), Fuyinjie (Fuyinjie), fuhuangsong (Fuyinjie), yuanantang (Yinhu Ganmao), yuanantang (Changwei), yuanantang (Zhuhu Huayu) tincture, etc. Several kinds of national medicines developed and produced by the company are all original ecological Chinese herbal medicines from the southeast of Guangxi. They are carefully extracted, scientifically combined and have their own characteristics. After more than 30 years of tempering and baptism, all kinds of Chinese medicine products of the company have formed the characteristics of "original ecological technology innovation type" and "market-oriented brand practical type". Fuyinjie ® compound Huangsong lotion and wipes are the pillar products of the company. They have formed and enriched the marketing system covering OTC drugstore sales, hospital sales, chain sales, etc., and established a reasonable marketing network in nearly 30 provinces, municipalities and autonomous regions. Yuanantang Yinhu Ganmao powder, yuanantang Changwei powder and yuanantang Zhuhu Huayu tincture are the only national characteristic drugs in Guangxi and even in China, showing unique curative effect. Yuanantang ® Yinhu Ganmao powder is an innovative national medicine with artemisinin as the main component, which is widely used in children and middle-aged and elderly people. In the early treatment of cold, it has become a model of no injection, no medicine, sticking navel therapy and treating cold. It has won the national invention patent, won the "special contribution award for scientific and technological invention of the Ministry of education, culture and health of the World Health Organization", and is rich in people in Guangxi Traditional Chinese medicine Ethnic medicine has maintained a strong momentum in the marketing of East China, central China and South China. The national medicine products, such as yuanantang ® changweisan and Zhuhu Huayu tincture, have their own characteristics in clinical practice, significant curative effect, great potential for sales and development, and infinite medical business opportunities and market value. Over the past 30 years of development, the company has adhered to the development path of scientific and technological innovation and strong brand industry, made great efforts to cultivate and build the core competitiveness of the enterprise, with a total of 17 technical invention and creation and various product trademark patents. The company has transformed scientific and technological research and development achievements into social productivity, which is conducive to promoting the harmonious development of social economy in Guangxi. The continuous promotion and development of the company's "yuanantang" and "Fuyinjie" brands endow them with rich scientific and technological connotation and potential brand value. Due to the influence of the company's national medicine brand, the growth rate of market sales and the sense of identity of the majority of consumers. Guangxi yuanantang Pharmaceutical Co., Ltd. will, under the correct leadership of the party committees and governments at all levels in Guangxi Autonomous Region, under the careful guidance of Guangxi food and Drug Administration and the Forestry Department of Guangxi Autonomous Region, combine its own advantages, take the market as the guide, research and development as the driving force, benefit as the core, people-oriented, work hard, strengthen management, integrate resources, reform and innovation, and work hard, We will promote the development of local economy, build Guangxi's national brand of traditional Chinese medicine, and make further contributions to the development of traditional Chinese medicine and human health.

本文链接: https://www.waitui.com/brand/5f02b73e7.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

“创新+国际化”步伐加快,多家创新药企“中考成绩”亮眼

记者梳理发现,截至目前,百济神州、翰森制药等多家创新药企披露上半年业绩情况,创新药收入情况、研发管线进展、出海规划等成为市场关注焦点。业内人士表示,当前我国创新药相关企业已经实现从量变到质变的转化,逐渐从“跟跑者”到“引领者”。创新药板块景气度有望持续,“创新+国际化”步伐逐渐加快,成为医药板块的核心方向。(中证报)

38分钟前

商业化带动需求提升,eVTOL动力电池路径渐明

随着eVTOL(电动垂直起降飞行器)订单密集落地,其商业化进程不断加速。与此同时,GWh级别的电池需求也逐渐显现。专家表示,面对航空级电池更为严格的要求,固态电池因兼具高能量密度与高安全性的特点,应用潜力较大,或将成为eVTOL厂商的核心选择。不过,固态电池在技术、供应链、成本等方面仍存在亟待突破的难题,其商业化之路依然漫长。在此背景下,混动路线成为部分厂商关注的焦点。业内预计,在未来相当长一段时间,混动路线会在eVTOL领域占有一席之地。(上证报)

38分钟前

马斯克称SpaceX明年收入将超过NASA预算

马斯克周四在X平台上发帖称:“SpaceX今年将从NASA获得的收入大约是10亿美元,约占150亿美元总收入的7%。”一位用户评论称:“很快,SpaceX的收入可能就会超过NASA的全部预算。”马斯克回应称:“明年。”根据美国白宫今年5月份公布的2026财年联邦支出预算提案,美国国家航空航天局(NASA)2026财年分配预算为188亿美元,较2025财年实际获得的249亿美元下降了近25%。(新浪财经)

38分钟前

稀土价格快速走高,稀土板块迎来业绩反转

稀土主要品种价格快速走高,8月以来平均上涨超过10万元/吨。与此同时,永磁体价格也快速走高,钕铁硼N35最新报价144.5元/千克,月内涨幅10.7%,年内涨幅51.3%。2024年,稀土价格大幅走低,A股稀土板块业绩暴跌,在业绩低基数和稀土价格走高的双重影响下,今年稀土板块迎来业绩反转。据数据宝统计,截至8月21日,已有14家稀土永磁个股发布上半年业绩数据(含预告、快报和年报),多数公司业绩预增或扭亏。龙头股北方稀土净利润更是同比暴增超18倍。(证券时报)

38分钟前

特斯拉未及时提交事故报告,美监管部门对其发起审查

美国国家公路交通安全管理局(NHTSA)下属缺陷调查办公室当地时间8月19日称,特拉斯未按照规定及时提交事故报告,NHTSA因此将启动审查,评估潜在报告延迟的原因、延迟的范围,以及特斯拉为解决这些问题所采取的缓解措施。作为此次审查的一部分,NHTSA还将评估是否仍有先前事故的报告未提交,以及已提交的报告是否包含所有必要且可用的数据。(界面)

38分钟前

本页详细列出关于肤阴洁的品牌信息,含品牌所属公司介绍,肤阴洁所处行业的品牌地位及优势。
咨询